Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia

Acute promyeloid leukemia (APL) is characterized by the oncogenic fusion protein PML-RARα, a major etiological agent in APL. However, the molecular mechanisms underlying the role of PML-RARα in leukemogenesis remain largely unknown. Using an inducible system, we comprehensively analyze the 3D genome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genome Biology 2020-05, Vol.21 (1), p.110-110, Article 110
Hauptverfasser: Wang, Ping, Tang, Zhonghui, Lee, Byoungkoo, Zhu, Jacqueline Jufen, Cai, Liuyang, Szalaj, Przemyslaw, Tian, Simon Zhongyuan, Zheng, Meizhen, Plewczynski, Dariusz, Ruan, Xiaoan, Liu, Edison T, Wei, Chia-Lin, Ruan, Yijun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Acute promyeloid leukemia (APL) is characterized by the oncogenic fusion protein PML-RARα, a major etiological agent in APL. However, the molecular mechanisms underlying the role of PML-RARα in leukemogenesis remain largely unknown. Using an inducible system, we comprehensively analyze the 3D genome organization in myeloid cells and its reorganization after PML-RARα induction and perform additional analyses in patient-derived APL cells with native PML-RARα. We discover that PML-RARα mediates extensive chromatin interactions genome-wide. Globally, it redefines the chromatin topology of the myeloid genome toward a more condensed configuration in APL cells; locally, it intrudes RNAPII-associated interaction domains, interrupts myeloid-specific transcription factors binding at enhancers and super-enhancers, and leads to transcriptional repression of genes critical for myeloid differentiation and maturation. Our results not only provide novel topological insights for the roles of PML-RARα in transforming myeloid cells into leukemia cells, but further uncover a topological framework of a molecular mechanism for oncogenic fusion proteins in cancers.
ISSN:1474-760X
1474-7596
1474-760X
DOI:10.1186/s13059-020-02030-2